Please provide your email address to receive an email when new articles are posted on . Researchers found no differences in mean arterial pressure between experimental and control groups. The rate of ...
EDEN PRAIRIE, Minn., Feb. 03, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced ...
Fifth Eye, a Michigan-based real-time clinical analytics company, announced today that the Food and Drug Administration has granted De Novo classification for its Analytic for Hemodynamic Instability ...
OAKLAND, Calif.--(BUSINESS WIRE)--Dascena, Inc., a machine learning diagnostic algorithm company that is targeting early disease intervention to improve patient care outcomes, today announced the ...
The FDA has granted de novo authorization to Fifth Eye Inc. for its Analytic for Hemodynamic Instability (AHI), a machine learning (ML)-based, real-time indicator of patient deterioration.
Patients treated with the MitraClip (Abbott) at one of three European hospitals were more likely to survive and avoid rehospitalization if they fit a “COAPT-like profile” based on echocardiography ...
A device driven by artificial intelligence that works to predict when a patient will deteriorate could provide a more accurate picture than traditional vital signs, a new study suggests. The ...
FIZE Medical Inc., a leader in smart fluid management solutions for critically ill patients, announced today an exclusive distribution agreement with Asahi Kasei Medical Co., Ltd. to launch the FIZE ...
The FDA has issued an Emergency Use Authorization (EUA) to a clinical decision support (CDS) tool that predicts when an adult patient admitted to the hospital with COVID-19 is at risk of further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback